Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome

Azra Raza email, Naomi Galili email, Natalie Callander email, Leonel Ochoa email, Lawrence Piro email, Peter Emanuel email, Stephanie Williams email, Howard Burris III email, Stefan Faderl email, Zeev Estrov email, Peter Curtin email, Richard A Larson email, James G Keck email, Marsha Jones email, Lisa Meng email and Gail L Brown email

Journal of Hematology & Oncology 2009, 2:20doi:10.1186/1756-8722-2-20

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.